Ravulizumab
Products in Health Canada’s databases that list Ravulizumab as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 3
- 2 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 11
- Products in all
- 3
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| ULTOMIRIS (300 MG) | 02533448 | Marketed | Alexion Pharma Gmbh | |
| ULTOMIRIS (1100 MG) | 02533456 | Marketed | Alexion Pharma Gmbh | |
| ULTOMIRIS (10 MG) | 02491559 | Cancelled Post Market | Alexion Pharma Gmbh |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- ULTOMIRISAugust 5, 2026 · NOC 38041
- ULTOMIRISDecember 3, 2025 · NOC 36547
- ULTOMIRISAugust 2, 2024 · NOC 33765
- ULTOMIRISOctober 30, 2023 · NOC 31965
- ULTOMIRISJuly 28, 2023 · NOC 31355
- ULTOMIRISJanuary 6, 2023 · NOC 29861
- ULTOMIRISDecember 13, 2022 · NOC 29686
- ULTOMIRISNovember 1, 2022 · NOC 29356
- ULTOMIRISSeptember 22, 2021 · NOC 26742
- ULTOMIRISFebruary 8, 2021 · NOC 25175
- ULTOMIRISAugust 28, 2019 · NOC 22577